Adjunctive Impact of Mitochondria-Targeting Antibiotics for Cancer Stem Cells of Oral Squamous Cell Carcinoma: Proposal for a Novel Approach in Resistant Cases.
作者信息
Amiri Mohammad Amin, Abbasi Hesam, Hamedani Shahram, Daneste Hossein
机构信息
Oral and Dental Disease Research Center, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
Postgraduate Student, Dept. of Oral and Maxillofacial Surgery, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
出版信息
J Dent (Shiraz). 2024 Sep 1;25(3):190-191. doi: 10.30476/dentjods.2024.102852.2397. eCollection 2024 Sep.
Abstract
摘要
相似文献
1
Adjunctive Impact of Mitochondria-Targeting Antibiotics for Cancer Stem Cells of Oral Squamous Cell Carcinoma: Proposal for a Novel Approach in Resistant Cases.线粒体靶向抗生素对口腔鳞状细胞癌癌症干细胞的辅助作用：针对耐药病例的新方法建议
J Dent (Shiraz). 2024 Sep 1;25(3):190-191. doi: 10.30476/dentjods.2024.102852.2397. eCollection 2024 Sep.
2
Mitochondria in oral cancer stem cells: Unraveling the potential drug targets for new and old drugs.口腔癌细胞中的线粒体：为新药和老药揭示潜在的药物靶点。
Life Sci. 2023 Oct 15;331:122065. doi: 10.1016/j.lfs.2023.122065. Epub 2023 Sep 1.
3
FTY720 increases paclitaxel efficacy in cisplatin-resistant oral squamous cell carcinoma.FTY720 提高顺铂耐药口腔鳞状细胞癌中紫杉醇的疗效。
J Oral Pathol Med. 2024 Jan;53(1):42-52. doi: 10.1111/jop.13498. Epub 2023 Nov 9.
4
Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma.组蛋白去乙酰化酶 6 的药理学抑制通过靶向口腔鳞状细胞癌中的癌症干细胞克服顺铂化疗耐药性。
J Oral Pathol Med. 2022 Jul;51(6):529-537. doi: 10.1111/jop.13326. Epub 2022 Jun 28.
5
[Cancer stem cells in oral squamous cell carcinoma. Literature review].[口腔鳞状细胞癌中的癌症干细胞。文献综述]
Rev Cient Odontol (Lima). 2022 Jun 27;10(2):e106. doi: 10.21142/2523-2754-1002-2022-106. eCollection 2022 Apr-Jun.
6
A novel MCT1 and MCT4 dual inhibitor reduces mitochondrial metabolism and inhibits tumour growth of feline oral squamous cell carcinoma.一种新型 MCT1 和 MCT4 双重抑制剂可降低线粒体代谢并抑制猫口腔鳞状细胞癌的肿瘤生长。
Vet Comp Oncol. 2020 Sep;18(3):324-341. doi: 10.1111/vco.12551. Epub 2019 Nov 19.
7
lncRNA HOXA11-AS maintains the stemness of oral squamous cell carcinoma stem cells and reduces the radiosensitivity by targeting miR-518a-3p/PDK1.长链非编码RNA HOXA11-AS通过靶向miR-518a-3p/丙酮酸脱氢酶激酶1维持口腔鳞状细胞癌干细胞的干性并降低其放射敏感性。
J Oral Pathol Med. 2023 Mar;52(3):216-225. doi: 10.1111/jop.13405. Epub 2023 Feb 15.
8
Cancer stem cell markers in patterning differentiation and in prognosis of oral squamous cell carcinoma.癌症干细胞标志物在口腔鳞状细胞癌的模式分化和预后中的作用
Tumour Biol. 2017 Jun;39(6):1010428317703656. doi: 10.1177/1010428317703656.
9
Quality of Life Assessment With European Organisation for Research and Treatment of Cancer Questionnaire (Head and Neck Module 43) and Its Clinicopathological Correlation Among Patients Treated for Oral Squamous Cell Carcinoma: An Exploratory Study.使用欧洲癌症研究与治疗组织问卷（头颈部模块43）对头颈部鳞状细胞癌患者进行生活质量评估及其临床病理相关性：一项探索性研究。
Cureus. 2023 Feb 5;15(2):e34650. doi: 10.7759/cureus.34650. eCollection 2023 Feb.
10
The selective toxicity of superparamagnetic iron oxide nanoparticles (SPIONs) on oral squamous cell carcinoma (OSCC) by targeting their mitochondria.超顺磁性氧化铁纳米颗粒（SPIONs）通过靶向口腔鳞状细胞癌（OSCC）的线粒体对其产生选择性毒性。
J Biochem Mol Toxicol. 2021 Jun;35(6):1-8. doi: 10.1002/jbt.22769. Epub 2021 Mar 11.
本文引用的文献
1
Current Treatment Strategies and Risk Stratification for Oral Carcinoma.口腔癌的当前治疗策略和风险分层。
Am Soc Clin Oncol Educ Book. 2023 May;43:e389810. doi: 10.1200/EDBK_389810.
2
Personalized Targeted Therapeutic Strategies against Oral Squamous Cell Carcinoma. An Evidence-Based Review of Literature.针对口腔鳞状细胞癌的个体化靶向治疗策略。基于证据的文献综述。
Int J Nanomedicine. 2022 Sep 15;17:4293-4306. doi: 10.2147/IJN.S377816. eCollection 2022.
3
Assessing Gene Expression Related to Cisplatin Resistance in Human Oral Squamous Cell Carcinoma Cell Lines.评估人口腔鳞状细胞癌细胞系中与顺铂耐药相关的基因表达
Pharmaceuticals (Basel). 2022 Jun 3;15(6):704. doi: 10.3390/ph15060704.
4
The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma.口腔鳞状细胞癌中顺铂耐药的分子基础与治疗研究进展
Front Oncol. 2021 Oct 22;11:761379. doi: 10.3389/fonc.2021.761379. eCollection 2021.
5
Survival-Weighted Health Profiles in Patients Treated for Advanced Oral Cavity Squamous Cell Carcinoma.晚期口腔鳞状细胞癌患者的生存加权健康概况
Front Oncol. 2021 Sep 29;11:754412. doi: 10.3389/fonc.2021.754412. eCollection 2021.
6
Clinical relevance of cancer stem cell chemotherapeutic assay for recurrent ovarian cancer.复发性卵巢癌的癌症干细胞化疗检测的临床相关性
Transl Oncol. 2020 Dec;13(12):100860. doi: 10.1016/j.tranon.2020.100860. Epub 2020 Aug 28.
7
Cancer stem cells and oral cancer: insights into molecular mechanisms and therapeutic approaches.癌症干细胞与口腔癌：分子机制及治疗方法的见解
Cancer Cell Int. 2020 Apr 7;20:113. doi: 10.1186/s12935-020-01192-0. eCollection 2020.
8
Cancer stem cells as key drivers of tumour progression.肿瘤干细胞作为肿瘤进展的关键驱动因素。
J Biomed Sci. 2018 Mar 6;25(1):20. doi: 10.1186/s12929-018-0426-4.
9
Cancer of the oral cavity.口腔癌
Surg Oncol Clin N Am. 2015 Jul;24(3):491-508. doi: 10.1016/j.soc.2015.03.006. Epub 2015 Apr 15.
10
Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease.靶向线粒体的抗生素可有效根除多种肿瘤类型中的癌症干细胞：像治疗传染病一样治疗癌症。
Oncotarget. 2015 Mar 10;6(7):4569-84. doi: 10.18632/oncotarget.3174.
Zotero 插件